Hussman Strategic Advisors’s Halozyme HALO Stock Holding History

Hussman Strategic Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29M	Sell	42,000 -10,500	-20%	-$716K	0.76%	30
2026 Q1	$3.39M	Hold	52,500	–	–	0.73%	19
2025 Q4	$3.53M	Buy	52,500 +21,000	+67%	+$1.41M	0.85%	10
2025 Q3	$2.31M	Sell	31,500 -52,500	-63%	-$3.49M	0.5%	69
2025 Q2	$4.37M	Buy	84,000 +10,500	+14%	+$597K	1%	14
2025 Q1	$4.69M	Hold	73,500	–	–	1.14%	9
2024 Q4	$3.51M	Buy	73,500 +31,500	+75%	+$1.62M	1.04%	12
2024 Q3	$2.4M	Hold	42,000	–	–	0.59%	64
2024 Q2	$2.2M	Buy	42,000 +10,500	+33%	+$460K	0.61%	66
2024 Q1	$1.28M	Hold	31,500	–	–	0.3%	127
2023 Q4	$1.16M	Hold	31,500	–	–	0.26%	146
2023 Q3	$1.2M	Sell	31,500 -15,000	-32%	-$614K	0.23%	170
2023 Q2	$1.68M	Hold	46,500	–	–	0.31%	148
2023 Q1	$1.78M	Buy	46,500 +21,700	+88%	+$1.02M	0.28%	146
2022 Q4	$1.41M	Sell	24,800 -6,200	-20%	-$317K	0.23%	167
2022 Q3	$1.23M	Buy	31,000 +21,700	+233%	+$959K	0.21%	177
2022 Q2	$409K	Buy	+9,300	New	+$402K	0.07%	276

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Hussman Strategic Advisors's HALO Position: Q2 2026 in Review

Hussman Strategic Advisors reduced its Halozyme (HALO) stake by 20% in Q2 2026, selling an estimated $716K and leaving 42,000 shares worth $3.29M. The position accounts for 0.76% of the portfolio, ranked #30.

Hussman Strategic Advisors first reported a position in HALO in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.69M in Q1 2025. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Hussman Strategic Advisors held 42,000 shares of Halozyme worth $3.29M as of Q2 2026.
Hussman Strategic Advisors sold 10,500 Halozyme shares in Q2 2026, an estimated $716K.
Halozyme made up 0.76% of Hussman Strategic Advisors's portfolio in Q2 2026, its #30 holding.
Hussman Strategic Advisors first reported a position in Halozyme in Q2 2022 and has held it in 17 quarters since.
Hussman Strategic Advisors's Halozyme position peaked at $4.69M in Q1 2025.
672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.